newsfilter
← Latest News
PR Newswire·

U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's Disease

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved JUVMO™ (tavapadon) tablets as the first and only...